Ijeoma Uchegbu

Q: What Schools Are Affiliated With Ijeoma Uchegbu

Ijeoma Uchegbu is affiliated with the following schools: University of Strathclyde, Imperial College London, University College London, University of Lagos, University of Benin , Queen Mary University of London

Ijeoma Uchegbu's AcademicInfluence.com Rankings

Ijeoma Uchegbu

Chemistry

#2284

World Rank

#3174

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Why Is Ijeoma Uchegbu Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ijeoma Uchegbu is a Nigerian-British Professor of Pharmacy at University College London where she held the position of Pro-Vice Provost for Africa and the Middle East. She is the Chief Scientific Officer of Nanomerics, a pharmaceutical nanotechnology company specialising in drug delivery solutions for poorly water-soluble drugs, nucleic acids and peptides. She is also a Governor of the Wellcome, a large biomedical research charity. Apart from her highly cited scientific research in Pharmaceutical Nanoscience, Uchegbu is also known for her work in science public engagement and equality and diversity in Science, Technology, Engineering and Mathematics .

(See a Problem?)

Ijeoma Uchegbu's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Non-ionic surfactant based vesicles (niosomes) in drug delivery (1998) (954)
Dendrimers in gene delivery. (2005) (896)
Health economic burden that wounds impose on the National Health Service in the UK (2015) (484)
Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry (1995) (420)
Gene delivery with synthetic (non viral) carriers. (2001) (338)
Health economic burden that different wound types impose on the UK's National Health Service (2017) (300)
The Lower-Generation Polypropylenimine Dendrimers Are Effective Gene-Transfer Agents (2002) (281)
Amphiphilic poly(L-amino acids) - new materials for drug delivery. (2012) (133)
The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. (2000) (133)
Preferential liver gene expression with polypropylenimine dendrimers. (2005) (127)
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. (2005) (127)
The release of model macromolecules may be controlled by the hydrophobicity of palmitoyl glycol chitosan hydrogels. (2002) (123)
Preliminary characterization of novel amino acid based polymeric vesicles as gene and drug delivery agents. (2000) (121)
Polymeric Chitosan‐based Vesicles for Drug Delivery (1998) (121)
PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility. (2004) (118)
Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. (2003) (113)
Strategies to deliver peptide drugs to the brain. (2014) (109)
Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles. (2012) (109)
Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude. (2006) (104)
Anticancer Drug Delivery with Transferrin Targeted Polymeric Chitosan Vesicles (2004) (102)
A non-covalently cross-linked chitosan based hydrogel. (1999) (102)
Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. (2004) (96)
Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs, Edited by R.H. Muller, S. Benita, B. Bohm, Medpharm Scientific Publishers, Stuttgart, 1998. ISBN 3-88763-069-6 (2001) (95)
Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles. (2015) (93)
Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain. (2004) (93)
Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles. (2012) (90)
Controls on Polymer Molecular Weight May Be Used To Control the Size of Palmitoyl Glycol Chitosan Polymeric Vesicles (2001) (90)
Quaternary ammonium palmitoyl glycol chitosan--a new polysoap for drug delivery. (2000) (90)
Distribution, Metabolism and Tumoricidal Activity of Doxorubicin Administered in Sorbitan Monostearate (Span 60) Niosomes in the Mouse (1995) (88)
Niosomes and Polymeric Chitosan Based Vesicles Bearing Transferrin and Glucose Ligands for Drug Targeting (2000) (87)
Polymers in Drug Delivery (2004) (82)
Nose-to-Brain Delivery (2019) (81)
Evaluation of Generation 2 and 3 Poly(Propylenimine) Dendrimers for the Potential Cellular Delivery of Antisense Oligonucleotides Targeting the Epidermal Growth Factor Receptor (2004) (76)
Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy (2012) (75)
Cancer-specific transgene expression mediated by systemic injection of nanoparticles. (2009) (75)
In silico modelling of drug–polymer interactions for pharmaceutical formulations (2010) (69)
A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain. (2012) (66)
The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery. (2009) (66)
Nanofiber-based delivery of therapeutic peptides to the brain. (2013) (65)
Pharmaceutical nanotechnology: polymeric vesicles for drug and gene delivery (2006) (64)
Polyelectrolyte nanoparticles with high drug loading enhance the oral uptake of hydrophobic compounds. (2006) (62)
Niosomes containing N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin (PK1) : effect of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution (1997) (57)
The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumour models. (1996) (57)
Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical/tubular niosomes. (1999) (56)
Nose to brain delivery in rats: Effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization. (2017) (55)
Erratum: Non-ionic surfactant based vesicles (niosomes) in drug delivery (International Journal of Pharmaceutics 172 (1998) (33-70) PII: S0378517398001690) (1998) (54)
Pharmaceutical and biological characterisation of a doxorubicin-polymer conjugate (PK1) entrapped in sorbitan monostearate Span 60 niosomes (1997) (53)
In vitro and in vivo gene transfer with poly(amino acid) vesicles. (2003) (52)
The effect of polymer architecture on the nano self-assemblies based on novel comb-shaped amphiphilic poly(allylamine) (2008) (51)
Label‐free imaging of polymeric nanomedicines using coherent anti‐stokes Raman scattering microscopy (2012) (48)
Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia (2018) (46)
The Level of Hydrophobic Substitution and the Molecular Weight of Amphiphilic Poly-L-lysine-Based Polymers Strongly Affects Their Assembly into Polymeric Bilayer Vesicles. (2001) (43)
LARGE DISK-SHAPED STRUCTURES (DISCOMES) IN NONIONIC SURFACTANT VESICLE TO MICELLE TRANSITIONS (1992) (41)
The evaluation of crown ether based niosomes as cation containing and cation sensitive drug delivery systems (1997) (41)
Nanomedicines and nanodiagnostics come of age. (2013) (40)
Gene Transfer with Three Amphiphilic Glycol Chitosans—the Degree of Polymerisation is the Main Controller of Transfection Efficiency (2004) (40)
Fundamentals of Pharmaceutical Nanoscience (2013) (37)
Imaging cortical vasculature with stimulated Raman scattering and two‐photon photothermal lensing microscopy (2012) (36)
Designing medical technology for resilience: integrating health economics and human factors approaches (2018) (35)
Liposomes encapsulating polymeric chitosan based vesicles--a vesicle in vesicle system for drug delivery. (2000) (34)
The molecular shape of poly(propylenimine) dendrimer amphiphiles has a profound effect on their self assembly. (2010) (33)
In vitro/in vivo characterisation of polyhedral niosomes. (1999) (31)
Physical characterisation and long-term stability studies on quaternary ammonium palmitoyl glycol chitosan (GCPQ)--a new drug delivery polymer. (2014) (31)
Polyhedral Non‐ionic Surfactant Vesicles (1997) (29)
Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration. (2015) (29)
Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels – A Strategy for Brain Cancer Treatments (2016) (28)
Polymeric amphiphile branching leads to rare nanodisc shaped planar self-assemblies. (2008) (27)
Nanomedicines for the Delivery of Biologics (2019) (27)
Adverse Drug Events Related to Dosage Forms and Delivery Systems (1996) (26)
Phase transitions in aqueous dispersions of the hexadecyl diglycerol ether (C(16)G(2)) non-ionic surfactant, cholesterol and cholesteryl poly-24-oxyethylene ether: Vesicles, tubules, discomes and micelles (1996) (26)
Chitosan amphiphiles provide new drug delivery opportunities (2014) (26)
A New Class of Amphiphilic Poly-l-lysine Based Polymers Forms Nanoparticles on Probe Sonication in Aqueous Media (2000) (25)
Amphotericin B Formulations – The Possibility of Generic Competition (2013) (24)
The biodistribution of novel 200-nm palmitoyl muramic acid vesicles (1998) (24)
The Effect of Monomers and of Micellar and Vesicular Forms of Non‐ionic Surfactants (Solulan C24 and Solulan 16) on Caco‐2 Cell Monolayers (1997) (24)
PARENTERAL DRUG DELIVERY : 2 (1999) (24)
The oral delivery of amphotericin B. (2013) (24)
A nano-enabled cancer-specific ITCH RNAi chemotherapy booster for pancreatic cancer. (2015) (21)
Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images. (2019) (21)
The Encapsulation of Bleomycin Within Chitosan Based Polymeric Vesicles Does Not Alter its Biodistribution (2000) (21)
Efficacy of DOPE/DC-cholesterol liposomes and GCPQ micelles as AZD6244 nanocarriers in a 3D colorectal cancer in vitro model. (2016) (20)
SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray (2021) (19)
Hydration forces as a tool for the optimization of core–shell nanoparticle vectors for cancer gene therapy (2012) (18)
Quantification of β-galactosidase activity after non-viral transfection in vivo (2003) (18)
Drug distribution and a pulmonary adverse effect of intraperitoneally administered doxorubicin niosomes in the mouse (1994) (18)
Early Economic Evaluation of Diagnostic Technologies: Experiences of the NIHR Diagnostic Evidence Co-operatives (2019) (18)
The polyacrylic acid/modified chitosan capsules with tunable release of small hydrophobic probe and drug (2015) (18)
Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors. (2017) (15)
A POLYMERIC AQUEOUS TACROLIMUS FORMULATION FOR TOPICAL OCULAR DELIVERY. (2021) (12)
Niosome encapsulation of a doxorubicin polymer conjugate (1996) (12)
Some aspects of the niosomal delivery of doxorubicin. (1994) (12)
The Oral and Intranasal Delivery of Propofol Using Chitosan Amphiphile Nanoparticles (2014) (12)
Cancer and the blood–brain barrier: ‘Trojan horses’ for courses? (2008) (12)
Nanomedicines in the treatment of brain tumors. (2018) (11)
Optimisation of synthetic vector systems for cancer gene therapy - the role of the excess of cationic dendrimer under physiological conditions. (2014) (10)
Poly(lactic-co-glycolic acid) Microspheres (2006) (10)
Direct in vivo evidence on the mechanism by which nanoparticles facilitate the absorption of a water insoluble, P-gp substrate. (2016) (10)
Polymers and dendrimers for gene delivery in gene therapy (2008) (9)
Dextran-pegylated microparticles for enhanced cellular uptake of hydrophobic drugs. (2013) (8)
High-resolution 3D isotropic MR imaging of mouse flank tumours obtained in vivo with solenoid RF micro-coil (2008) (8)
SOME RHEOLOGICAL PROPERTIES OF NONIONIC SURFACTANT VESICLES AND THE DETERMINATION OF SURFACE HYDRATION (1999) (8)
Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis (2019) (8)
Nanotechnology in Advanced Drug Delivery (2011) (8)
Osmotic Behaviour of Polyhedral Non‐ionic Surfactant Vesicles (Niosomes) (1999) (8)
Nanostructures overcoming the blood-brain barrier:physiological considerations and mechanistic issues (2012) (8)
Quantification of beta-galactosidase activity after non-viral transfection in vivo. (2003) (7)
Dendrimers in gene delivery B (2005) (7)
Integrating human factors and health economics to inform the design of medical device: a conceptual framework (2017) (6)
SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray (2020) (6)
Unusual Enthalpy Driven Self Assembly at Room Temperature with Chitosan Amphiphiles (2019) (6)
Achieving highly efficient gene transfer to the bladder by increasing the molecular weight of polymer-based nanoparticles. (2021) (6)
Polymeric Micelles for the Enhanced Deposition of Hydrophobic Drugs into Ocular Tissues, without Plasma Exposure (2021) (6)
Drug delivery across the blood-brain barrier (2011) (5)
Dendrimer-Based Gene Delivery Systems: Administration Routes and In Vivo Evaluation (2012) (5)
Surface enhanced deep Raman detection of cancer tumour through 71 mm of heterogeneous tissue (2022) (5)
The lower critical solution temperature of doxorubicin polymer conjugates (1996) (5)
Polymer Hydrophobicity Has a Positive Effect on the Oral Absorption of Cyclosporine A from Poly(ethylenimine) Based Nanomedicines (2012) (5)
Tissue-Engineering the Fibrous Pancreatic Tumour Stroma Capsule in 3D Tumouroids to Demonstrate Paclitaxel Response (2021) (4)
Claw amphiphiles with a dendrimer core: nanoparticle stability and drug encapsulation are directly proportional to the number of digits. (2013) (4)
Polymeric Nanoparticles as Drug Carriers (2006) (4)
13 Dendrimers in Drug and Gene Delivery (2006) (4)
Low Molecular Weight Micelles (2013) (4)
Nanotechnology in Drug Delivery (2010) (3)
Ultrasmall-in-Nano: Why Size Matters (2022) (3)
Polyamine aza-cyclic compounds demonstrate anti-proliferative activity in vitro but fail to control tumour growth in vivo. (2010) (3)
Hydrogel Drug Delivery Systems (2006) (3)
Hyaluronidase coated MET nanoparticles enhance drug absorption via the subcutaneous route. (2020) (3)
Polymeric Micelles as Pharmaceutical Carriers (2006) (3)
Special Section on Drug Delivery Technologies — Minireview Nose-to-Brain Delivery (2019) (3)
The Role of Polymers in Solid Oral Dosage Forms (2006) (3)
Facile aqueous, room temperature preparation of high transverse relaxivity clustered iron oxide nanoparticles (2019) (3)
Hydrogels for drug delivery via the buccal route (2000) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis. (2021) (3)
A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production (2020) (2)
Star Shaped Poly(ethylene glycols) Yield Biocompatible Gene Delivery Systems (2014) (2)
Polymer Characterization Techniques (2006) (2)
Polymers Used for the Delivery of Genes in Gene Therapy (2006) (2)
Tumour gene expression from C12 spermine amphiphile gene delivery systems (2005) (2)
An investigation into the phase behaviour of polyhedral niosomes using high sensitivity differential scanning calorimetry (1997) (2)
The Topical Ocular Delivery of Rapamycin to Posterior Eye Tissues and the Suppression of Retinal Inflammatory Disease. (2022) (2)
Non-ionic surfactant vesicle (niosome) phase transitions (1996) (2)
Vesicles prepared from synthetic amphiphiles — polymeric vesicles and niosomes (2006) (2)
Dendrimers for gene therapy (2016) (2)
A Cost Analysis of Cardiac Magnetic Resonance Imaging in the Diagnostic Pathway of Patients Presenting With Unexplained Acute Myocardial Injury and Culprit-Free Coronary Angiography (2021) (2)
The blood brain barrier and drug transport. (2012) (2)
Detecting polymeric nanoparticles with coherent anti-stokes Raman scattering microscopy in tissues exhibiting fixative-induced autofluorescence (2015) (2)
Amphotericin B Polymer Nanoparticles Show Efficacy against Candida Species Biofilms (2022) (2)
Q of b-galactosidase activity after non-viral transfection in vivo (2003) (2)
T-shaped Peptide Amphiphiles Self Assemble into Nanofiber Networks. (2018) (2)
Oral administration of a nano-enabled form of Met-Enkephalin peptide controls pancreatic cancer growth (2015) (1)
Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure. (2022) (1)
Erratum to “Quaternary ammonium palmitoyl glycol chitosan—a new polysoap for drug delivery”: [Int. J. Pharm. 224 (2001) 185–199] (2001) (1)
THE ACTIVITY OF DOXORUBICIN NIOSOMES AGAINST A RESISTANT HUMAN OVARIAN CANCER CELL LINE (1993) (1)
Hyaluronidase Coated Molecular Envelope Technology Nanoparticles Enhance Drug Absorption via the Subcutaneous Route (2020) (1)
Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes (2022) (1)
Selecting the Right Polymer for Biomaterial Applications (2006) (1)
Computer aided optimisation of synthetic gene delivery agents using PPI dendrimers (2002) (1)
Polymeric vesicles from modified polyethylenimine polymers for gene delivery (2000) (1)
Polymeric vesicles from amino acid homopolymers (1998) (1)
Handbook of pharmaceutical controlled release technology, Edited by Donald L. Wise; ISBN Number: 0-8247-0369-3 (2001) (1)
Modified glycol chitosan nanocarriers carry hydrophobic materials into tumours (2010) (1)
Nanoparticles and polymeric vesicles from new poly-L-lysine based amphiphiles (2000) (1)
Development of Bio-Functionalized, Raman Responsive, and Potentially Excretable Gold Nanoclusters (2021) (1)
Gene and Ribonucleic Acid Therapy (2013) (1)
Investigations into the in‐vitro/in‐vivo behaviour of polyhedral niosomes (1998) (1)
Nanotechnology in pharmaceuticals-NANOTECHNOLOGY IN DRUG DELIVERY (2010) (1)
Gambling with antibiotics: a novel approach for exploring antibiotic consumption decision-making. (2017) (1)
Chitosan based polymeric vesicles as anti-cancer drug carriers (1998) (0)
Nanoparticulate Mycophenolic Acid Eye Drops - Analytical Validation of a High Performance Liquid Chromatography Assay and Stability Studies. (2021) (0)
Dendrimers for use in targeted administration (2002) (0)
Oral polymeric nanomedicines for peptide delivery to the brain : Polymer molecular weight effect (2011) (0)
Effect of Vegetable Based Lubricants on Equal Channel Angular Extrusion Pressure (2017) (0)
A cost analysis of cardiac magnetic resonance imaging in the diagnostic pathway of a population with unexplained acute myocardial injury and normal coronary angiography (2021) (0)
The challenges of patient and public involvement in medical technology and in-vitro diagnostic research (2018) (0)
Dufès, Christine and Schätzlein, A.G. and Tetley, L. and Gray, A.I. and Watson, D.G. and Olivier, J.C. and Couet, W. and Uchegbu, I.F. (2000) Niosomes and polymeric chitosan based vesicles bearing transferrin (2018) (0)
FULL TITLE Size-tuneable Nanometric MRI Contrast Agents for the Imaging of Molecular Weight Dependent Transport Processes AUTHORS NAMES AND AFFILIATION (2015) (0)
Editorial (2007) (0)
Abstract: In-vivo biodistribution of amphiphilic polymer quaternary ammonium palmitoyl glycol chitosan in mice (2009) (0)
Polymer Based Gene Silencing: In Vitro Delivery of SiRNA. (2016) (0)
EDITORIAL (2003) (0)
A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production (2020) (0)
Nanostructures as tools for CNS delivery (2012) (0)
Fast gelation of self-assembling peptide nanofibres triggered by electromagnetic radiation heating (2011) (0)
Amphiphilic polymer aggregates and their exploitation as bioavailability enhancement nanomedicines (2005) (0)
Spot light- Professor Vladimir P. Torchilin (2013) (0)
Editorial (2007) (0)
pharmaceutical formulations polymer interactions for − modelling of drug In silico (2010) (0)
Meet Our Editor-in-Chief (2015) (0)
Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform (2023) (0)
El-Hammadi, Mazen M. and MacLellan, Steven and Dufès, Christine and Holmes, William M. and Condon, Barrie and Uchegbu, Ijeoma F. and Schatzlein, Andreas G. (2014) Size-tuneable nanometric MRI contrast agents for the imaging of molecular weight dependent transport (2018) (0)
Editorial-It’s here! (2012) (0)
Use of a composition comprising nanofibers containing a peptide conjugated to a lipophilic group, for the delivery of a peptide across the blood brain barrier in a therapy of the human or animal body (2012) (0)
Gavin Brooks, Gene Therapy – The Use of DNA as a Drug. London: Pharmaceutical Press, 2002 (2002) (0)
An Assessment of the Role of Polymers for Drug Delivery in Tissue Engineering (2006) (0)
Verifying Engineering at the Nanoscale (2007) (0)
Transcriptionally targeted synthetic gene medicines combine anti-cancer activity of therapeutic genes and cationic polymer to achieve long term responses in established solid tumors after systemic adminstration (2006) (0)
Artificial intelligence for detection of Alzheimer's disease: demonstration of real-world value is required to bridge the translational gap. (2022) (0)
Engineering of GCPQ Polymer Allows Graded Modulation of Trans-and Paracellular Epithelial Drug Transport Mechanisms (2017) (0)
Oral nanomedicines for the treatment of brain diseases (2011) (0)
Quantification of Epicardial Adipose Tissue Volume and Attenuation for Cardiac CT Scans Using Deep Learning in a Single Multi-Task Framework (2022) (0)
Applying advanced delivery technologies to enable and improve drug development. 8-9 December 2004, London, UK. (2005) (0)
Erratum: Council committees (Pharmaceutical Journal (60)) (2006) (0)
Amphiphilic chitosan based solubilisers. (2003) (0)
Abstract 4519: Lomustine nanoparticles are effective brain cancer treatments. (2013) (0)
THE BIODISTRIBUTION AND TUMORICIDAL ACTIVITY OF DOXORUBICIN‐LOADED NIOSOMES (1993) (0)
Editorial. (2020) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
The British Pharmaceutical Conference 2009. 6-9 September 2009, Manchester, UK. (2009) (0)
Characterization of a new class of amino-acid based polymers for gene delivery (1999) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
The hierarchical organization of carbohydrate amphiphiles into solubilising nanoparticles. (2004) (0)
Polymeric Vesicles Based on Hydrophilic Polymers Bearing Hydrophobic Pendant Groups (2016) (0)
Polymer–Drug Conjugates (2006) (0)
Novel amphiphilic polyethylenimine (PEIs) for oral delivery of poorly soluble drugs (2004) (0)
Blood-Brain Barrier Delivery Session Podium Presentation : Carbohydrate Amphiphiles Enable Oral Peptide Delivery to the Central Nervous System (2009) (0)
Ethnic Diversity in Science (2021) (0)
Drug transport and drug delivery--the Midnight Sun meeting. (2004) (0)
Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels – A Strategy for Brain Cancer Treatments (2016) (0)
Chapter 7.3:Drug Delivery Strategies: Nanostructures for Improved Brain Delivery (2012) (0)
Drug delivery gels from palmitoyl glycol chitosan (1998) (0)
Nanomedicines from polymeric amphiphiles (2010) (0)
Brain Gene Silencing with Cationic Amino-Capped Poly(ethylene glycol) Polyplexes (2022) (0)
POS0842 NON-INVASIVE COHERENT RAMAN IMAGING OF INVOLVED FOREARM SKIN REVEALS ALIGNED COLLAGEN IN DERMIS OF SYSTEMIC SCLEROSIS PATIENTS (2022) (0)
Polymers in drug delivery - Preface (2004) (0)
Chitosan based hydrogels for macromolecular drug delivery (1998) (0)
Bringing Molecular Diagnostic Tests Into Clinical Practice: Mapping The Evidence Pathway (2017) (0)
Size-tuneable Nanometric MRI Contrast Agents for the Imaging of Molecular Weight Dependent Transport Processes (2015) (0)
Preliminary characterization of amino acid based polymeric vesicles for gene delivery (1998) (0)
DNA Interaction with polymeric vesicles - consequences for the transfection efficiency (in vitro) (1998) (0)
EDITORIAL: Emerging Bio-inspired and Bio-Compatible Nanomaterials in 21st Century. (2018) (0)
Editorial (2010) (0)
The polyacrylic acid / modified chitosan capsules with tunable release of small hydrophobic guests (2016) (0)
Carbohydrate Amphiphiles Enable Peptide Delivery to the CNS (2008) (0)
Abstract 5530: Chitosan amphiphile nanoparticles reduced the myelosuppressive effects of lomustine (2015) (0)
Editorial. (2020) (0)
Lomustine nanoparticles are effective brain cancer treatments. (2013) (0)

This paper list is powered by the following services:

Other Resources About Ijeoma Uchegbu

What Schools Are Affiliated With Ijeoma Uchegbu?

Ijeoma Uchegbu is affiliated with the following schools:

Ijeoma Uchegbu's Academic­Influence.com Rankings